{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:45Z","timestamp":1794028305172,"version":"4.8.0"},"reference-count":127,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several important physiological processes, from permeability to inflammation to hemostasis, take place at the vessel wall and are regulated by endothelial cells (ECs). Thus, proteins that have been identified as regulators of one process are increasingly found to be involved in other vascular functions. Such is the case for von Willebrand factor (VWF), a large glycoprotein best known for its critical role in hemostasis. In vitro and in vivo studies have shown that lack of VWF causes enhanced vascularization, both constitutively and following ischemia. This evidence is supported by studies on blood outgrowth EC (BOEC) from patients with lack of VWF synthesis (type 3 von Willebrand disease [VWD]). The molecular pathways are likely to involve VWF binding partners, such as integrin \u03b1v\u03b23, and components of Weibel-Palade bodies, such as angiopoietin-2 and galectin-3, whose storage is regulated by VWF; these converge on the master regulator of angiogenesis and endothelial homeostasis, vascular endothelial growth factor signaling. Recent studies suggest that the roles of VWF may be tissue specific. The ability of VWF to regulate angiogenesis has clinical implications for a subset of VWD patients with severe, intractable gastrointestinal bleeding resulting from vascular malformations. In this article, we review the evidence showing that VWF is involved in blood vessel formation, discuss the role of VWF high-molecular-weight multimers in regulating angiogenesis, and review the value of studies on BOEC in developing a precision medicine approach to validate novel treatments for angiodysplasia in congenital VWD and acquired von Willebrand syndrome.<\/jats:p>","DOI":"10.1182\/blood-2018-01-769018","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T22:05:37Z","timestamp":1528149937000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":219,"title":["von Willebrand factor regulation of blood vessel formation"],"prefix":"10.1182","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-211X","authenticated-orcid":false,"given":"Anna M.","family":"Randi","sequence":"first","affiliation":[{"name":"Vascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koval E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Vascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[{"name":"Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111909491378900_B1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12185-012-1041-x","article-title":"von Willebrand factor: at the crossroads of bleeding and thrombosis","volume":"95","author":"Denis","year":"2012","journal-title":"Int J Hematol"},{"issue":"1","key":"2019111909491378900_B2","doi-asserted-by":"crossref","first-page":"e2013046","DOI":"10.4084\/mjhid.2013.046","article-title":"On the versatility of von Willebrand factor","volume":"5","author":"Rauch","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"2019111909491378900_B3","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI107471","article-title":"Synthesis of antihemophilic factor antigen by cultured human endothelial cells","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"issue":"Pt 1","key":"2019111909491378900_B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1242\/jcs.03494","article-title":"Formation and function of Weibel-Palade bodies","volume":"121","author":"Metcalf","year":"2008","journal-title":"J Cell Sci"},{"issue":"2","key":"2019111909491378900_B5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2015-10-677054","article-title":"von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells","volume":"128","author":"Lopes da Silva","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2019111909491378900_B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(86)90735-X","article-title":"Inducible secretion of large, biologically potent von Willebrand factor multimers","volume":"46","author":"Sporn","year":"1986","journal-title":"Cell"},{"issue":"1","key":"2019111909491378900_B7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1083\/jcb.109.1.367","article-title":"Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism","volume":"109","author":"Dejana","year":"1989","journal-title":"J Cell Biol"},{"issue":"19","key":"2019111909491378900_B8","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4706","key":"2019111909491378900_B9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"issue":"9","key":"2019111909491378900_B10","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111909491378900_B11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5482\/HAMO-16-06-0018","article-title":"Von Willebrand factor processing","volume":"37","author":"Brehm","year":"2017","journal-title":"Hamostaseologie"},{"issue":"suppl 1","key":"2019111909491378900_B12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2009.03375.x","article-title":"von Willebrand factor assembly and secretion","volume":"7","author":"Sadler","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111909491378900_B13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050184","article-title":"Von Willebrand factor: molecular size and functional activity","volume":"72","author":"Furlan","year":"1996","journal-title":"Ann Hematol"},{"issue":"12","key":"2019111909491378900_B14","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111909491378900_B15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2008-06-160556","article-title":"Shear tango: dance of the ADAMTS13\/VWF complex","volume":"112","author":"de Groot","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111909491378900_B16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2019111909491378900_B17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(91)90648-I","article-title":"Induction of specific storage organelles by von Willebrand factor propolypeptide","volume":"64","author":"Wagner","year":"1991","journal-title":"Cell"},{"issue":"5","key":"2019111909491378900_B18","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1091\/mbc.01-09-0462","article-title":"Selective and signal-dependent recruitment of membrane proteins to secretory granules formed by heterologously expressed von Willebrand factor","volume":"13","author":"Blagoveshchenskaya","year":"2002","journal-title":"Mol Biol Cell"},{"issue":"7","key":"2019111909491378900_B19","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-02-0599","article-title":"Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor","volume":"102","author":"Michaux","year":"2003","journal-title":"Blood"},{"issue":"19","key":"2019111909491378900_B20","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1182\/blood-2010-09-267492","article-title":"Functional architecture of Weibel-Palade bodies","volume":"117","author":"Valentijn","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111909491378900_B21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"issue":"14","key":"2019111909491378900_B22","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2019111909491378900_B23","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111909491378900_B24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1538-7836.2012.04702.x","article-title":"Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111909491378900_B25","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1021\/pr300010r","article-title":"Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies","volume":"11","author":"van Breevoort","year":"2012","journal-title":"J Proteome Res"},{"issue":"21","key":"2019111909491378900_B26","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1242\/jcs.208033","article-title":"Weibel-Palade bodies at a glance","volume":"130","author":"McCormack","year":"2017","journal-title":"J Cell Sci"},{"issue":"5","key":"2019111909491378900_B27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.ATV.0000209501.56852.6c","article-title":"Dynamics and plasticity of Weibel-Palade bodies in endothelial cells","volume":"26","author":"Rondaij","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2019111909491378900_B28","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111909491378900_B29","first-page":"1471","article-title":"Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree","volume":"139","author":"Gebrane-Youn\u00e8s","year":"1991","journal-title":"Am J Pathol"},{"issue":"1","key":"2019111909491378900_B30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.23.1.101","article-title":"New cytoplasmic components in arterial endothelia","volume":"23","author":"Weibel","year":"1964","journal-title":"J Cell Biol"},{"key":"2019111909491378900_B31","first-page":"965","article-title":"The morphologic basis for normal endothelial permeability; intercellular pathways","volume":"82","author":"Simionescu","year":"1977","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2019111909491378900_B32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.ATV.7.3.287","article-title":"Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location","volume":"7","author":"Rand","year":"1987","journal-title":"Arteriosclerosis"},{"issue":"1","key":"2019111909491378900_B33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.ATV.7.1.47","article-title":"Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease","volume":"7","author":"Wu","year":"1987","journal-title":"Arteriosclerosis"},{"issue":"3","key":"2019111909491378900_B34","first-page":"673","article-title":"Antigenic heterogeneity of vascular endothelium","volume":"141","author":"Page","year":"1992","journal-title":"Am J Pathol"},{"issue":"5","key":"2019111909491378900_B35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2460\/ajvr.1996.57.05.750","article-title":"Differential distribution of von Willebrand factor in canine vascular endothelium","volume":"57","author":"Smith","year":"1996","journal-title":"Am J Vet Res"},{"issue":"8","key":"2019111909491378900_B36","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V92.8.2791","article-title":"Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo","volume":"92","author":"Yamamoto","year":"1998","journal-title":"Blood"},{"issue":"5","key":"2019111909491378900_B37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1083\/jcb.138.5.1117","article-title":"Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment","volume":"138","author":"Aird","year":"1997","journal-title":"J Cell Biol"},{"issue":"7","key":"2019111909491378900_B38","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/ATVBAHA.110.206680","article-title":"Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice","volume":"30","author":"Nassiri","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2019111909491378900_B39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.1996.4661005.x","article-title":"Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo","volume":"93","author":"Senis","year":"1996","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111909491378900_B40","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V94.10.3405.422k28_3405_3412","article-title":"Characterization of the mouse von Willebrand factor promoter","volume":"94","author":"Guan","year":"1999","journal-title":"Blood"},{"issue":"21","key":"2019111909491378900_B41","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1182\/blood-2012-12-473785","article-title":"Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium","volume":"121","author":"Yuan","year":"2013","journal-title":"Blood"},{"key":"2019111909491378900_B42","doi-asserted-by":"crossref","first-page":"10160","DOI":"10.1038\/ncomms10160","article-title":"A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity","volume":"7","author":"Yuan","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"2019111909491378900_B43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI106480","article-title":"Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand\u2019s dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor","volume":"50","author":"Zimmerman","year":"1971","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111909491378900_B44","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI107469","article-title":"Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy","volume":"52","author":"Hoyer","year":"1973","journal-title":"J Clin Invest"},{"issue":"14","key":"2019111909491378900_B45","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0959-8049(96)00379-6","article-title":"Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation","volume":"32A","author":"Vermeulen","year":"1996","journal-title":"Eur J Cancer"},{"issue":"51","key":"2019111909491378900_B46","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1038\/sj.onc.1210535","article-title":"The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells","volume":"26","author":"Ito","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"2019111909491378900_B47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C281::AID-IJC21%3E3.0.CO;2-3","article-title":"Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis","volume":"85","author":"Zanetta","year":"2000","journal-title":"Int J Cancer"},{"key":"2019111909491378900_B48","article-title":"A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma [published online ahead of print 28 March 2018]","author":"Pace","journal-title":"J Neurooncol"},{"issue":"10","key":"2019111909491378900_B49","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"2019111909491378900_B50","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70003-3","article-title":"Diagnosis and treatment of acquired von Willebrand syndrome","volume":"130","author":"Tiede","year":"2012","journal-title":"Thromb Res"},{"issue":"5","key":"2019111909491378900_B51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/hae.12243","article-title":"Erik von Willebrand","volume":"19","author":"Lassila","year":"2013","journal-title":"Haemophilia"},{"issue":"3","key":"2019111909491378900_B52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0002-9343(77)90846-4","article-title":"von Willebrand\u2019s disease and hemorrhagic telangiectasia: association of two complex disorders of hemostasis resulting in life-threatening hemorrhage","volume":"62","author":"Ahr","year":"1977","journal-title":"Am J Med"},{"issue":"6","key":"2019111909491378900_B53","first-page":"981","article-title":"Capillary microscopic and rheological dimensions for the diagnosis of von Willebrand disease in comparison to other haemorrhagic diatheses","volume":"84","author":"Koscielny","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111909491378900_B54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01649509","article-title":"Angiodysplasia--an uncommon cause of colonic bleeding: colonoscopic evaluation of 1,050 patients with rectal bleeding and anaemia","volume":"2","author":"Danesh","year":"1987","journal-title":"Int J Colorectal Dis"},{"issue":"8","key":"2019111909491378900_B55","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archinte.1995.00430080037005","article-title":"Angiodysplasia and lower gastrointestinal tract bleeding in elderly patients","volume":"155","author":"Sharma","year":"1995","journal-title":"Arch Intern Med"},{"issue":"3","key":"2019111909491378900_B56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0038-1649623","article-title":"International survey of patients with von Willebrand disease and angiodysplasia","volume":"70","author":"Fressinaud","year":"1993","journal-title":"Thromb Haemost"},{"issue":"12","key":"2019111909491378900_B57","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2004.40459.x","article-title":"Gastrointestinal angiodysplasia in a patient with type 2 von Willebrand\u2019s disease and analysis of exon 28 of the von Willebrand factor gene","volume":"99","author":"Satoh","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"2019111909491378900_B58","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.thromres.2006.01.022","article-title":"Gastrointestinal bleeding in von Willebrand disease","volume":"118","author":"Makris","year":"2006","journal-title":"Thromb Res"},{"issue":"4","key":"2019111909491378900_B59","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111909491378900_B60","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111909491378900_B61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1160\/TH10-11-0697","article-title":"Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance","volume":"105","author":"Castaman","year":"2011","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111909491378900_B62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12571","article-title":"The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease","volume":"21","author":"Makris","year":"2015","journal-title":"Haemophilia"},{"issue":"4","key":"2019111909491378900_B63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0887-7963(03)00037-3","article-title":"Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome","volume":"17","author":"Warkentin","year":"2003","journal-title":"Transfus Med Rev"},{"issue":"3","key":"2019111909491378900_B64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ageing\/afp019","article-title":"Heyde syndrome: a common diagnosis in older patients with severe aortic stenosis","volume":"38","author":"Massyn","year":"2009","journal-title":"Age Ageing"},{"issue":"4","key":"2019111909491378900_B65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111909491378900_B66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMp030055","article-title":"Aortic stenosis, von Willebrand factor, and bleeding","volume":"349","author":"Sadler","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111909491378900_B67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.athoracsur.2010.04.099","article-title":"Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients","volume":"90","author":"Crow","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"2019111909491378900_B68","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"issue":"2","key":"2019111909491378900_B69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12272","article-title":"Von Willebrand disease-associated angiodysplasia: a few answers, still many questions","volume":"161","author":"Franchini","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111909491378900_B70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","article-title":"Prophylaxis in severe forms of von Willebrand\u2019s disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"issue":"6","key":"2019111909491378900_B71","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.dld.2018.02.004","article-title":"Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: a position paper of the Italian Society of Gastroenterology (SIGE)","volume":"50","author":"Nardone","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"9423","key":"2019111909491378900_B72","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"2019111909491378900_B73","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1440-1746.2011.06967.x","article-title":"Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide","volume":"27","author":"Tan","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2019111909491378900_B74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","article-title":"Statins and the endothelium","volume":"46","author":"Ii","year":"2007","journal-title":"Vascul Pharmacol"},{"issue":"10","key":"2019111909491378900_B75","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3109\/00365529609003126","article-title":"Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia","volume":"31","author":"Andersen","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2019111909491378900_B76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1988.tb02502.x","article-title":"High-dose intravenous gammaglobulin for acquired von Willebrand\u2019s disease","volume":"70","author":"Delannoy","year":"1988","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111909491378900_B77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.2830410212","article-title":"Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate","volume":"41","author":"Castaman","year":"1992","journal-title":"Am J Hematol"},{"issue":"10","key":"2019111909491378900_B78","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/jth.13112","article-title":"Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease","volume":"13","author":"Groeneveld","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111909491378900_B79","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MBC.0000000000000635","article-title":"Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients","volume":"28","author":"Selvam","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"2019111909491378900_B80","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood-2011-04-348706","article-title":"Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane","volume":"119","author":"Scheppke","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111909491378900_B81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2016-10-747089","article-title":"ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery","volume":"130","author":"Xu","year":"2017","journal-title":"Blood"},{"issue":"7","key":"2019111909491378900_B82","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1160\/TH16-12-0957","article-title":"von Willebrand factor deficiency leads to impaired blood flow recovery after ischaemia in mice","volume":"117","author":"de Vries","year":"2017","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111909491378900_B83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jth.13551","article-title":"Von Willebrand factor and angiogenesis: basic and applied issues","volume":"15","author":"Randi","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111909491378900_B84","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1513\/pats.201102-021MW","article-title":"Vascular endothelial growth factor and vascular homeostasis","volume":"8","author":"Lazarus","year":"2011","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"2019111909491378900_B85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1572-0241.1999.01017.x","article-title":"Increased expression of angiogenic factors in human colonic angiodysplasia","volume":"94","author":"Junquera","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"36","key":"2019111909491378900_B86","doi-asserted-by":"crossref","first-page":"17703","DOI":"10.1016\/S0021-9258(18)45436-1","article-title":"Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor","volume":"262","author":"Cheresh","year":"1987","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111909491378900_B87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","article-title":"Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis","volume":"12","author":"Somanath","year":"2009","journal-title":"Angiogenesis"},{"issue":"2","key":"2019111909491378900_B88","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/path.3018","article-title":"Focal adhesion kinase and tumour angiogenesis","volume":"226","author":"Lechertier","year":"2012","journal-title":"J Pathol"},{"issue":"3","key":"2019111909491378900_B89","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"42","key":"2019111909491378900_B90","doi-asserted-by":"crossref","first-page":"15491","DOI":"10.1073\/pnas.0607538103","article-title":"Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells","volume":"103","author":"Daly","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111909491378900_B91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/0008-5472.CAN-12-2064","article-title":"Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition","volume":"73","author":"Daly","year":"2013","journal-title":"Cancer Res"},{"key":"2019111909491378900_B92","first-page":"175","article-title":"Defective angiopoietin-2 release from von Willebrand disease patients\u2019 blood outgrowth endothelial cells","volume":"11","author":"Starke","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111909491378900_B93","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/joc.2010.22.6.402","article-title":"Overexpression of vascular endothelial growth factor 165 (VEGF165) protects cardiomyocytes against doxorubicin-induced apoptosis","volume":"22","author":"Chen","year":"2010","journal-title":"J Chemother"},{"issue":"16","key":"2019111909491378900_B94","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.gt.3302296","article-title":"Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial \u2018delivery-efficacy\u2019 mismatch","volume":"11","author":"Radke","year":"2004","journal-title":"Gene Ther"},{"issue":"10","key":"2019111909491378900_B95","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/glycob\/cwu086","article-title":"Galectin-3 in angiogenesis and metastasis","volume":"24","author":"Funasaka","year":"2014","journal-title":"Glycobiology"},{"issue":"9","key":"2019111909491378900_B96","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1084\/jem.20090121","article-title":"Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response","volume":"207","author":"Markowska","year":"2010","journal-title":"J Exp Med"},{"issue":"4","key":"2019111909491378900_B97","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/ATVBAHA.111.240309","article-title":"Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor","volume":"32","author":"Saint-Lu","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2019111909491378900_B98","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MCG.0000000000000260","article-title":"Expression of angiogenic factors in patients with sporadic small bowel angiodysplasia","volume":"49","author":"Holleran","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"2019111909491378900_B99","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1160\/TH17-06-0397","article-title":"Circulating angiogenic mediators in patients with moderate and severe von willebrand disease: a multicentre cross-sectional study","volume":"118","author":"Groeneveld","year":"2018","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111909491378900_B100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D\u2019D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111909491378900_B101","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V92.2.529","article-title":"Binding of factor VIII to von Willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers","volume":"92","author":"Bendetowicz","year":"1998","journal-title":"Blood"},{"issue":"5","key":"2019111909491378900_B102","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2003-07-2267","article-title":"von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate","volume":"103","author":"Keuren","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111909491378900_B103","doi-asserted-by":"crossref","first-page":"e73715","DOI":"10.1371\/journal.pone.0073715","article-title":"The interaction between factor H and Von Willebrand factor","volume":"8","author":"Feng","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2019111909491378900_B104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","article-title":"von Willebrand factor. A reduced and alkylated 52\/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib","volume":"261","author":"Fujimura","year":"1986","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111909491378900_B105","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/S0021-9258(19)50746-3","article-title":"Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis","volume":"267","author":"Beacham","year":"1992","journal-title":"J Biol Chem"},{"issue":"10","key":"2019111909491378900_B106","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood-2005-09-3635","article-title":"P-selectin binds to the D\u2019-D3 domains of von Willebrand factor in Weibel-Palade bodies","volume":"107","author":"Michaux","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2019111909491378900_B107","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/ATVBAHA.115.305259","article-title":"Choline transporter-like protein-2: new von Willebrand factor-binding partner involved in antibody-mediated neutrophil activation and transfusion-related acute lung injury","volume":"35","author":"Bayat","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"26","key":"2019111909491378900_B108","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"issue":"12","key":"2019111909491378900_B109","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2006-03-010322","article-title":"P-selectin glycoprotein ligand 1 and \u03b22-integrins cooperate in the adhesion of leukocytes to von Willebrand factor","volume":"108","author":"Pendu","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2019111909491378900_B110","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3324\/haematol.2012.063297","article-title":"Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5","volume":"97","author":"Pegon","year":"2012","journal-title":"Haematologica"},{"issue":"9","key":"2019111909491378900_B111","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"issue":"28","key":"2019111909491378900_B112","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111909491378900_B113","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.ATV.13.3.398","article-title":"Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen","volume":"13","author":"Denis","year":"1993","journal-title":"Arterioscler Thromb"},{"issue":"20","key":"2019111909491378900_B114","doi-asserted-by":"crossref","first-page":"21439","DOI":"10.1074\/jbc.M313560200","article-title":"Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice","volume":"279","author":"Pimanda","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111909491378900_B115","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0021-9258(19)75700-7","article-title":"A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728","volume":"262","author":"Fujimura","year":"1987","journal-title":"J Biol Chem"},{"issue":"6","key":"2019111909491378900_B116","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0049-3848(97)00096-0","article-title":"Binding of the von Willebrand factor A1 domain to histone","volume":"86","author":"Ward","year":"1997","journal-title":"Thromb Res"},{"issue":"7","key":"2019111909491378900_B117","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/ATVBAHA.113.303016","article-title":"von Willebrand factor directly interacts with DNA from neutrophil extracellular traps","volume":"34","author":"Gr\u00e4ssle","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"2019111909491378900_B118","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.698.698","article-title":"Von Willebrand factor binds to the endothelial growth factor angiopoietin-2 both within endothelial cells and upon release from Weibel Palade bodies [abstract]","volume":"118","author":"Mckinnon","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111909491378900_B119","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1538-7836.2007.02768.x","article-title":"Efficiency of von Willebrand factor-mediated targeting of interleukin-8 into Weibel-Palade bodies","volume":"5","author":"Bierings","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019111909491378900_B120","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1538-7836.2007.02681.x","article-title":"Characterization of the interaction between von Willebrand factor and osteoprotegerin","volume":"5","author":"Shahbazi","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111909491378900_B121","first-page":"87","article-title":"The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding","volume":"116","author":"Parker","year":"2016","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111909491378900_B122","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1365-2141.2000.01897.x","article-title":"Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand\u2019s disease","volume":"108","author":"Bowers","year":"2000","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111909491378900_B123","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2516.2006.01210.x","article-title":"Von Willebrand\u2019s disease and angiodysplasia treated with thalidomide","volume":"12","author":"Hirri","year":"2006","journal-title":"Haemophilia"},{"issue":"6","key":"2019111909491378900_B124","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1365-2516.2009.02085.x","article-title":"Type IIb von Willebrand disease with angiodysplasias and refractory gastrointestinal bleeding successfully treated with thalidomide","volume":"15","author":"Nomikou","year":"2009","journal-title":"Haemophilia"},{"issue":"2","key":"2019111909491378900_B125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2008.07005.x","article-title":"Von Willebrand disease and angiodysplasia responding to atorvastatin","volume":"142","author":"Sohal","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111909491378900_B126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.2009.08031.x","article-title":"Von Willebrand disease, angiodysplasia and atorvastatin","volume":"149","author":"Alikhan","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111909491378900_B127","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1111\/hae.12196","article-title":"Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand\u2019s disease","volume":"19","author":"Thachil","year":"2013","journal-title":"Haemophilia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/2\/132\/1406941\/blood769018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/2\/132\/1406941\/blood769018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T08:12:38Z","timestamp":1720339958000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/132\/2\/132\/39222\/von-Willebrand-factor-regulation-of-blood-vessel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,7,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-01-769018","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]}}}